Back to Journals » Hepatic Medicine: Evidence and Research » Volume 3
Hepatic Medicine: Evidence and Research
ISSN: 1179-1535
- View all (191)
- Volume 16, 2024 (6)
- Volume 15, 2023 (22)
- Volume 14, 2022 (13)
- Volume 13, 2021 (16)
- Volume 12, 2020 (16)
- Volume 11, 2019 (16)
- Volume 10, 2018 (13)
- Volume 9, 2017 (10)
- Volume 8, 2016 (15)
- Volume 7, 2015 (8)
- Volume 6, 2014 (12)
- Volume 5, 2013 (7)
- Volume 4, 2012 (7)
- Volume 3, 2011 (14)
- Volume 2, 2010 (14)
- Volume 1, 2009 (2)
Archive: Volume 3, 2011
Rifaximin in the treatment of hepatic encephalopathy
Iadevaia MD, Del Prete A, Cesaro C, Gaeta L, Zulli C, Loguercio C
Hepatic Medicine: Evidence and Research 2011, 3:109-117
Published Date: 22 December 2011
A newborn liver mass that never existed: a somber reminder of embryonic ties between umbilical vein and portal venous system
Haafiz A, Williams JL, Andres JM, Novak DA
Hepatic Medicine: Evidence and Research 2011, 3:107-108
Published Date: 14 December 2011
Decline in HAV-associated fulminant hepatic failure and liver transplant in children in Argentina after the introduction of a universal hepatitis A vaccination program
Cervio G, Trentadue J, D´Agostino DE, Luque C, Giorgi MA, Armoni J, Debbag R
Hepatic Medicine: Evidence and Research 2011, 3:99-106
Published Date: 19 September 2011
Inhibition of Notch signaling affects hepatic oval cell response in rat model of 2AAF-PH
Darwiche H, Oh S-H, Steiger-Luther NC, Williams JM, Pintilie DG, Shupe TD, Petersen BE
Hepatic Medicine: Evidence and Research 2011, 3:89-98
Published Date: 5 September 2011
Autonomic dysfunction in chronic liver disease
Frith J, Newton JL
Hepatic Medicine: Evidence and Research 2011, 3:81-87
Published Date: 23 August 2011
Reversal of hepatic fibrosis: pathophysiological basis of antifibrotic therapies
Ismail MH, Pinzani M
Hepatic Medicine: Evidence and Research 2011, 3:69-80
Published Date: 4 July 2011
Selected biochemical and hematological abnormalities in Nigerians with human immunodeficiency virus and hepatitis C virus coinfection
Obienu O, Nwokediuko SC
Hepatic Medicine: Evidence and Research 2011, 3:63-68
Published Date: 30 June 2011
Evolving concepts in the selection of immunosuppression regimen for liver transplant recipients
Locke JE, Singer AL
Hepatic Medicine: Evidence and Research 2011, 3:53-62
Published Date: 13 May 2011
Type I interferon receptor in peripheral blood mononuclear cells may predict response to intra-arterial 5-fluorouracil + interferon therapy for advanced hepatocellular carcinoma
Tomiyama Y, Yoshioka N, Yanai Y, Kawase T, Nishina S, Hara Y, Yoshida K, Korenaga K, Korenaga M, Hino K
Hepatic Medicine: Evidence and Research 2011, 3:45-52
Published Date: 26 April 2011
Scavenger receptor class B member 1 protein: hepatic regulation and its effects on lipids, reverse cholesterol transport, and atherosclerosis
Kent AP, Stylianou IM
Hepatic Medicine: Evidence and Research 2011, 3:29-44
Published Date: 8 April 2011
Critical reappraisal of risk factors for occurrence of hepatocellular carcinoma in patients with hepatitis C virus
Bruno S, Savojardo D, Almasio PL, Mondelli MU
Hepatic Medicine: Evidence and Research 2011, 3:21-28
Published Date: 30 March 2011
Erratum
Xiao N, Shi S, Zhuang H
Hepatic Medicine: Evidence and Research 2011, 3:19-20
Published Date: 18 March 2011
Serum anti-modified citrullinated vimentin antibody concentration is associated with liver fibrosis in patients with chronic hepatitis
Suad Abdeen, Samuel O Olusi, Sunila George
Hepatic Medicine: Evidence and Research 2011, 3:13-18
Published Date: 10 March 2011
Pathogenesis and management of alcoholic liver cirrhosis: a review
Yi-Wen Huang, Sien-Sing Yang, Jia-Horng Kao
Hepatic Medicine: Evidence and Research 2011, 3:1-11
Published Date: 24 December 2010